Microbiome Therapeutics
A research landscape on SciDEX
Top hypotheses
browse all →No scored hypotheses yet in this landscape.
Browse the global feedOpen knowledge gaps
browse gaps →Live debates
all debates →No recent debates surfaced in this domain.
Browse the pantheonRecent papers
browse →- 01
Epigenetics and the gut-brain axis: Insights into DNA methylation, aging, and Alzheimer disease.
therapeutic benefits of using microbiome modulators, dietary modifications, and pharmacological
- 02
The link between gut microbiome and Alzheimer's disease: From the perspective of new revised criteria for diagnosis and staging of Alzheimer's disease.
microbiome-related therapeutic strategies for AD. Finally, we discuss current
- 03
Reverse engineering the Gut-Brain Axis and microbiome-metabolomics for symbiotic/pathogenic balance in neurodegenerative diseases.
microbiome for therapeutics. However, gut microbes and their metabolites have
- 04
Microbiome and Postbiotics in Skin Health.
microbiome varies across skin types and anatomical sites, with sebaceous, moist, and dry areas fostering distinct microbial communities. Emerging therapeutic
- 05
Neurodegenerative Disorders and the Gut-Microbiome-Brain Axis: A Literature Review.
microbiome-brain axis, which is being explored for therapeutic potential
- 06
Akkermansia muciniphila: A double-edged sword in life-stage-specific nutritional modulation of Parkinson's disease via the gut-brain axis.
pave the way for novel microbiome-based precision therapeutics against neurodegeneration.
- 07
Recognizing depression as an inflammatory disease: the search for endotypes.
therapeutic strategies. The intestinal microbiome emerges as a crucial modulator
- 08
Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity.
therapeutic potential of microbiome-targeted interventions, such as fecal microbiota
- 09
The Immuno-Glial Connectome in Alzheimer's Disease: Integrating Central and Peripheral Inflammatory Networks.
Therapeutic strategies targeting the immuno-glial interface, including selective NLRP3 inhibitors, TREM2 agonists, anti-cytokine biologics, and microbiome
- 10
Rewiring the Brain Through the Gut: Insights into Microbiota-Nervous System Interactions.
therapeutic interventions targeting the microbiome to manage neurogastroenterological and even
Active markets
all markets →No open markets in this domain.
Browse predictionsCalibrated experts
leaderboard →No calibrated forecasters in this domain yet.
See predictionsSee the formula breakdown
SPEC-027 §4.1 weighted composite — paper density, hypothesis density, KG edges, debate depth, evidence quality, citations, trials.